Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Refractory chronic diarrhea with duodenal and jejunal lesions.

Clinical endoscopy·2026
Same author

Correction: Intelligent catalase-coated MnO<sub>2</sub> nanoparticles with programmed oxygen supply and glutathione depletion for enhanced photodynamic therapy.

Journal of materials chemistry. B·2026
Same author

Tumor-Responsive Fluorogenic Spray for Image-Guided Cytoreduction of Disseminated Ovarian Tumors.

Bioconjugate chemistry·2025
Same author

Customized Nanofibers with Lung-Targeting and -Retention Properties for Treating Isolated Triple-Negative Breast Cancer Pulmonary Metastases.

ACS nano·2025
Same author

Iron-Doxorubicin Hyaluronan Nanogel as an Effective Targeted Chemotherapy with Modulated Cardiotoxicity.

Biomacromolecules·2025
Same author

Hijacking the hyaluronan assisted iron endocytosis to promote the ferroptosis in anticancer photodynamic therapy.

Carbohydrate polymers·2025

Related Experiment Video

Updated: Dec 29, 2025

Formulating and Characterizing Lipid Nanoparticles for Gene Delivery using a Microfluidic Mixing Platform
09:41

Formulating and Characterizing Lipid Nanoparticles for Gene Delivery using a Microfluidic Mixing Platform

Published on: February 25, 2021

24.8K

Multifunctional Nanodelivery Platform for Maximizing Nucleic Acids Combination Therapy.

Seung Koo Lee1, Benedict Law1, Ching-Hsuan Tung2

  • 1Department of Radiology, Weill Cornell Medicine, Molecular Imaging Innovations Institute, New York, NY, USA.

Methods in Molecular Biology (Clifton, N.J.)
|February 2, 2020
PubMed
Summary
This summary is machine-generated.

Developing novel nanodelivery platforms for cancer therapy is crucial. This study introduces a multifunctional nanovector for precisely delivering multiple therapeutic agents, enhancing combination treatments with reduced side effects.

Keywords:
Combination therapyElectrostatic interactionsGold nanoparticlesHyaluronic acidKLA peptideLayer-by-layerNucleic acidsPoly-L-lysineSmall interfering RNAmicroRNA

More Related Videos

Combining QD-FRET and Microfluidics to Monitor DNA Nanocomplex Self-Assembly in Real-Time
14:36

Combining QD-FRET and Microfluidics to Monitor DNA Nanocomplex Self-Assembly in Real-Time

Published on: August 26, 2009

11.5K
Generation of Cationic Nanoliposomes for the Efficient Delivery of In Vitro Transcribed Messenger RNA
08:29

Generation of Cationic Nanoliposomes for the Efficient Delivery of In Vitro Transcribed Messenger RNA

Published on: February 1, 2019

10.5K

Related Experiment Videos

Last Updated: Dec 29, 2025

Formulating and Characterizing Lipid Nanoparticles for Gene Delivery using a Microfluidic Mixing Platform
09:41

Formulating and Characterizing Lipid Nanoparticles for Gene Delivery using a Microfluidic Mixing Platform

Published on: February 25, 2021

24.8K
Combining QD-FRET and Microfluidics to Monitor DNA Nanocomplex Self-Assembly in Real-Time
14:36

Combining QD-FRET and Microfluidics to Monitor DNA Nanocomplex Self-Assembly in Real-Time

Published on: August 26, 2009

11.5K
Generation of Cationic Nanoliposomes for the Efficient Delivery of In Vitro Transcribed Messenger RNA
08:29

Generation of Cationic Nanoliposomes for the Efficient Delivery of In Vitro Transcribed Messenger RNA

Published on: February 1, 2019

10.5K

Area of Science:

  • Biomedical Engineering
  • Nanotechnology
  • Oncology

Background:

  • Small interfering RNA (siRNA) holds promise for cancer therapy by silencing oncogenes.
  • Combining siRNA with other therapeutics can improve efficacy, but simultaneous delivery is challenging.
  • Targeted delivery of multiple agents is essential for effective combination cancer therapy.

Purpose of the Study:

  • To develop a novel multifunctional nanodelivery platform for simultaneous delivery of multiple therapeutic agents.
  • To overcome the challenge of co-delivering siRNA and other active ingredients to cancer cells.
  • To enhance the efficacy of combination cancer therapy through precise and programmable delivery.

Main Methods:

  • Sequential layering of functional ingredients (siRNAs, microRNAs, peptides, targeting ligands) onto a core via charge-charge interactions.
  • Fabrication of multifunctional nanovectors capable of carrying multiple therapeutic payloads.
  • In vitro/in vivo evaluation of nanovector targeting efficiency and therapeutic payload delivery.

Main Results:

  • The developed nanovectors successfully encapsulated and delivered multiple active components, including siRNA, microRNA, and peptides.
  • Programmable and effective delivery of combined therapeutics to target sites was achieved.
  • Minimal off-targeting effects were observed, indicating high specificity of the nanodelivery system.

Conclusions:

  • The novel multifunctional nanodelivery platform enables effective combination cancer therapy by precisely delivering multiple agents.
  • This approach addresses the challenge of co-delivery, paving the way for enhanced therapeutic outcomes in oncology.
  • The nanovector system offers a promising strategy for maximizing therapeutic synergy while minimizing adverse effects.